September 2022

We are happy to announce that we will be part of this year's CIRSE in Barcelona.

plus medica will attend with a Hands-on Device Training „Peripheral mechanical thrombectomy“.

You can visit us in room 132 at the following times:
• HDT-PMT…

August 2022

Special thanks to Dr. Arun Kumarasamy for performing two successfull BYCROSS cases with his team.

Click here to see full LinkedIn post. 

August 2022

Thanks to Dr. med. Tolga Atilla Sagban and Prof. Dr. Walter Hundt for performing this case. We are happy about our BYCROSS results!

Click here to see full LinkedIn post. 

June 2022

We are happy to welcome you at IROS 22.
You can find us at booth nr. 35a.

IROS 2022 - Salzburg Austria. 

March 2022

After our first successful BYCROSS cases in Norway, we also had our first successful BYCROSS case in Sweden.
 
Thanks to Dr. Tal Hörer, Head of the department of endovascular and vascular surgery, at Örebro University Hospital for the first…

March 2022

Two more successful BYCROSS cases in Norway at St. Olav's University Hospital in Trondheim with Dr. Dordi Stensvåg Midelfart, Dr. Frode Manstad-Hulaas, Dr. Asbjørn Ødegård, Dr. Martin Herje and the team of the department of interventional…

March 2022

Thanks to our partner Angiocare. Congrats to Job Oldenziel, Jean-Paul de Vries and their surgical team from Interventional Radiology department for conducting 3 successfull BYCROSS cases in Groningen.

Angiocare:

"We wish to…

March 2022

We are proud to announce that we have successfully completed our first BYCROSS case in Scandinavia.
 
Congratulations to Dr. Jørg Geisler and Dr. Andreas Tjølsen and the team of the department of interventional radiology, Sykehuset i…

22.03.2022

Congratulations to the surgical team of Helios Klinikum Aue and their successful training in HS Hospital Service Amica RF ablation technology for benign thyroid nodules in ENT and endocrinology. 

Thanks to Lars van Lauwe for supporting our…

21.02.2022

Blueflow venous stent for chronic iliofemoral venous disease “offers favourable primary patency”.

Follow the link for this interesting outcome:

https://venousnews.com/blueflow-venous-stent-for-chronic-iliofemoral-venous-disease-offers-favou…